DK1131087T4 - Lindring af prostatacancersymptomer - Google Patents

Lindring af prostatacancersymptomer

Info

Publication number: DK1131087T4
Authority: DK; Denmark
Prior art keywords: relief; bmp; prostate cancer; cancer symptoms; gdf
Prior art date: 1998-11-13

Application number

DK99958892T

Other languages

English (en)

Other versions

DK1131087T3 (da

Inventor

Kuber T Sampath

Charles M Cohen

David C Rueger

Original Assignee

Stryker Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-13

Filing date

1999-11-12

Publication date

2009-08-03

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22704676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131087(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-12 Application filed by Stryker Corp filed Critical Stryker Corp

2004-12-13 Publication of DK1131087T3 publication Critical patent/DK1131087T3/da

2009-08-03 Application granted granted Critical

2009-08-03 Publication of DK1131087T4 publication Critical patent/DK1131087T4/da

Links

208000024891 symptom Diseases 0.000 title abstract 2
206010060862 Prostate cancer Diseases 0.000 title 1
208000000236 Prostatic Neoplasms Diseases 0.000 title 1
102100040898 Growth/differentiation factor 11 Human genes 0.000 abstract 2
101710194452 Growth/differentiation factor 11 Proteins 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 2
201000011510 cancer Diseases 0.000 abstract 2
KLXQAXYSOJNJRI-KVTDHHQDSA-N (2s,3s,4r,5r)-5-amino-2,3,4,6-tetrahydroxyhexanal Chemical compound OC[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)C=O KLXQAXYSOJNJRI-KVTDHHQDSA-N 0.000 abstract 1
102000003928 Bone morphogenetic protein 15 Human genes 0.000 abstract 1
108090000349 Bone morphogenetic protein 15 Proteins 0.000 abstract 1
108010090290 Growth Differentiation Factor 2 Proteins 0.000 abstract 1
102000004858 Growth differentiation factor-9 Human genes 0.000 abstract 1
108090001086 Growth differentiation factor-9 Proteins 0.000 abstract 1
102100040892 Growth/differentiation factor 2 Human genes 0.000 abstract 1
102100035379 Growth/differentiation factor 5 Human genes 0.000 abstract 1
101710204282 Growth/differentiation factor 5 Proteins 0.000 abstract 1
101000651373 Homo sapiens Serine palmitoyltransferase small subunit B Proteins 0.000 abstract 1
102000004472 Myostatin Human genes 0.000 abstract 1
108010056852 Myostatin Proteins 0.000 abstract 1
102100027676 Serine palmitoyltransferase small subunit B Human genes 0.000 abstract 1
230000010261 cell growth Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000001537 neural effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Hematology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Steroid Compounds (AREA)

DK99958892T 1998-11-13 1999-11-12 Lindring af prostatacancersymptomer DK1131087T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US19123998A	1998-11-13	1998-11-13
PCT/US1999/026636 WO2000029012A2 (en)	1998-11-13	1999-11-12	Methods of alleviating cancer symptoms

Publications (2)

Publication Number	Publication Date
DK1131087T3 DK1131087T3 (da)	2004-12-13
DK1131087T4 true DK1131087T4 (da)	2009-08-03

Family

ID=22704676

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99958892T DK1131087T4 (da)	1998-11-13	1999-11-12	Lindring af prostatacancersymptomer

Country Status (10)

Country	Link
EP (2)	EP1131087B2 (da)
JP (2)	JP4892131B2 (da)
AT (1)	ATE275416T1 (da)
AU (1)	AU1616700A (da)
CA (1)	CA2349038C (da)
DE (1)	DE69920033T3 (da)
DK (1)	DK1131087T4 (da)
ES (1)	ES2226467T5 (da)
PT (1)	PT1131087E (da)
WO (1)	WO2000029012A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10026713A1 (de) *	2000-05-30	2001-12-06	Walter Sebald	Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
ES2431929T3 (es) *	2001-09-18	2013-11-28	Genentech, Inc.	Composiciones y procedimientos para el diagnóstico y el tratamiento de tumores
WO2005097825A2 (en) *	2004-03-31	2005-10-20	Xencor, Inc.	Bmp-7 variants with improved properties
CN102443627B (zh) *	2004-08-10	2014-10-29	加的夫生物学有限公司	用于乳腺癌的预后的试剂盒
WO2006029406A2 (en) *	2004-09-09	2006-03-16	Stryker Corporation	Methods for treating bone tumors using bone morphogenic proteins
JP2008169116A (ja) *	2005-04-18	2008-07-24	Tokyo Medical & Dental Univ	Ｂｍｐ−７を含む抗ｃ型肝炎ウイルス剤
US7851435B2 (en)	2005-05-27	2010-12-14	Bbs-Bioactive Bone Substitutes Oy	Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
EP1885750B1 (en)	2005-05-27	2011-08-17	BBS - Bioactive Bone Substitutes Oy	Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof
EP1885751B1 (en)	2005-05-27	2011-11-16	BBS - Bioactive Bone Substitutes Oy	Bone morphogenetic protein 6 containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
NZ565172A (en) *	2005-07-19	2012-12-21	Stemgen S P A	Inhibition of the tumorigenic potential of tumor stem cells by LIF and BMPS
GB0615129D0 (en) *	2006-07-29	2006-09-06	Univ Cardiff	Anti-cancer activity of BMP-9 and BMP-10 and their use in cancer therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU660019B2 (en) †	1991-03-11	1995-06-08	Stryker Corporation	Protein-induced morphogenesis
US5652118A (en) †	1991-03-11	1997-07-29	Creative Biomolecules, Inc.	Nucleic acid encoding a novel morphogenic protein, OP-3
US5739107A (en) *	1991-03-11	1998-04-14	Creative Biomolecules, Inc.	Morphogen treatment of gastrointestinal ulcers
US6287816B1 (en) *	1991-06-25	2001-09-11	Genetics Institute, Inc.	BMP-9 compositions
EP0653942B2 (en) †	1992-07-31	2007-03-07	Curis, Inc.	Morphogen-induced nerve regeneration and repair
ATE198049T1 (de) *	1992-09-15	2000-12-15	Creative Biomolecules Inc	Behandlung von magen- und darmgeschwüren mit morphogenen
ATE378407T1 (de) †	1994-04-29	2007-11-15	Curis Inc	Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen
JPH08225454A (ja) *	1995-02-23	1996-09-03	Chugai Pharmaceut Co Ltd	マイクロスフェア製剤
FR2737501B1 (fr) *	1995-07-31	1997-10-24	Transgene Sa	Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants
AU7115996A (en) †	1995-09-21	1997-04-09	Trustees Of Columbia University In The City Of New York, The	Uses of bone morphogenetic proteins
WO1998050061A1 (en) *	1997-05-07	1998-11-12	Biogen, Inc.	Novel therapies for cystic kidney disease

1999
- 1999-11-12 PT PT99958892T patent/PT1131087E/pt unknown
- 1999-11-12 EP EP99958892A patent/EP1131087B2/en not_active Expired - Lifetime
- 1999-11-12 WO PCT/US1999/026636 patent/WO2000029012A2/en not_active Ceased
- 1999-11-12 CA CA2349038A patent/CA2349038C/en not_active Expired - Fee Related
- 1999-11-12 JP JP2000582058A patent/JP4892131B2/ja not_active Expired - Fee Related
- 1999-11-12 AT AT99958892T patent/ATE275416T1/de active
- 1999-11-12 AU AU16167/00A patent/AU1616700A/en not_active Abandoned
- 1999-11-12 DK DK99958892T patent/DK1131087T4/da active
- 1999-11-12 ES ES99958892T patent/ES2226467T5/es not_active Expired - Lifetime
- 1999-11-12 DE DE69920033T patent/DE69920033T3/de not_active Expired - Lifetime
- 1999-11-12 EP EP04008347A patent/EP1435243A3/en not_active Withdrawn
2010
- 2010-03-09 JP JP2010052381A patent/JP2010150278A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CA2349038C (en)	2011-08-02
JP2002529513A (ja)	2002-09-10
CA2349038A1 (en)	2000-05-25
DK1131087T3 (da)	2004-12-13
DE69920033T2 (de)	2005-09-22
ATE275416T1 (de)	2004-09-15
AU1616700A (en)	2000-06-05
EP1131087B2 (en)	2009-04-01
EP1435243A3 (en)	2005-02-09
WO2000029012A2 (en)	2000-05-25
JP4892131B2 (ja)	2012-03-07
PT1131087E (pt)	2004-12-31
ES2226467T5 (es)	2009-08-27
EP1131087B1 (en)	2004-09-08
EP1131087A2 (en)	2001-09-12
WO2000029012A3 (en)	2000-11-16
DE69920033T3 (de)	2009-10-08
ES2226467T3 (es)	2005-03-16
EP1435243A2 (en)	2004-07-07
JP2010150278A (ja)	2010-07-08
DE69920033D1 (de)	2004-10-14
WO2000029012A8 (en)	2001-01-11

Publication	Publication Date	Title
Moan et al.	1998	The biophysical foundations of photodynamic therapy
SE9900100D0 (sv)	1999-01-15	New compounds
EP1334731A4 (en)	2004-07-28	AGENT FOR PREVENTING OR TREATING PSORIASIS WITH AN IL-6 ANTAGONIST AS AN ACTIVE SUBSTANCE
EP2261200A3 (en)	2010-12-29	Modified forms of pharmacacologically active agents and uses therefor
CA2170700A1 (en)	1996-09-03	Pyrazolopyrimidines and Pyrrolopyrimidines for Treatment of Neuronal and Other Disorders
DE60121988D1 (de)	2006-09-14	Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
AU6613896A (en)	1996-10-30	Chemical compounds
PT1131087E (pt)	2004-12-31	Metodos de alivio de sintomas de cancro
DE60107234D1 (de)	2004-12-23	Antitubulinanordnung und zellenwachstumshemmstoff "dioxostatin"
BR0111892A (pt)	2003-07-01	Bis-arilsulfonas
EP1181935A3 (en)	2002-03-06	Agent for treating mental disorders associated with cerebrovascular disorders
NO20032762L (no)	2003-08-18	Aktivitetsstyringsanordning
BR0012553A (pt)	2002-04-16	Pastilhas contendo ambroxol
TR199901017A2 (xx)	1999-12-21	B�cek ilac� terkibi.
CA2153778A1 (en)	1994-07-21	Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
Ell	1998	Clinical photodynamic therapy: where is it heading?
WO2002099422A3 (en)	2003-03-06	Individualization of therapy with alzheimer's disease agents
TR199900124T2 (xx)	1999-03-22	Ha�ere �ld�r�c� bile�imler
Font et al.	1998	Finding the words: Instruments for a therapy of liberation
Coppola et al.	1993	Early retroduodenal perforation following endoscopic internal biliary drainage
ATE228841T1 (de)	2002-12-15	Nicorandil gegen angstneurosen
TR200103219T2 (tr)	2002-04-22	Nöropatik ağrının iyileştirilmesinde kullanım için aroil aminoasil piroller
CA2452432A1 (en)	2003-01-30	Active ingredient combination for the pharmacological therapy of nicotine dependence
WO2002040859A3 (en)	2003-04-24	System and method for generating a right torsion field
BR0017035A (pt)	2003-01-07	Combinação de trimebutina com um analgésico opióide